Thyrotoxicosis among hanford, washington, downwinders: A community-based health survey

Archives of Environmental Health

Volumn 57, Issue 1, 2002, Pages 9-15

  Grossman, Charles M ^a   Nussbaum, Rudi H ^b   Nussbaum, Fred D ^c  

^a LEGACY GOOD SAMARITAN HOSPITAL   (United States)

^b PORTLAND STATE UNIVERSITY   (United States)

^c Head and Neck Institute   (United States)

Author keywords

131i; Community based science; Graves' disease; Hanford; Hyperthyroidism; Radiation health effects; Radioactive fallout; Thyrotoxicosis; Washington

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADULT; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HEALTH SURVEY; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOACTIVE WASTE; THYROTOXICOSIS; TOXIC GOITER;

EID: 0036279887     PISSN: 00039896     EISSN: None     Source Type: Journal    
DOI: 10.1080/00039890209602911     Document Type: Article

References (42)

1. Fred Hutchinson Cancer Research Center. Draft Final Report of the Hanford Thyroid Disease Study (Mod. 11 March 1999), 1998. Available online: http://www.fhcrc.org/phs/htds/(16 June 1999).
2. Farris WT, Napier BA, lkenberry TA, et al. Radiation doses from Hanford site releases to the atmosphere and the Columbia River. Health Phys 1996; 71:588-601.
3. Robkin MA, Shleien B. Estimated maximum thyroid doses from '29l releases from the Hanford site for the years 1944-1995. Health Phys 1995; 69:917-22.
4. Grossman CM, Morton WE, Nussbaum RH. Hypothyroidism and spontaneous abortion among Hanford, Washington, Down-winders. Arch Environ Health 1996; 51:175-76. [Note: Data from the full cohort of 518 females confirmed our previous conclusions based on a smaller group of 335 female respondents.]
5. Goldsmith JR, Grossman CM, Morton WE, et al. Juvenile hypothyroidism among two populations exposed to radioiodine. Environ Health Perspect 1999; 107:303-08.
6. Washington State Department of Health. The Health of Washington State. Kelso S (Ed). Olympia, WA:5.48; September 1996.
7. Dawber TR. The Framingham Study. The epidemiology of atherosclerotic disease. Cambridge, MA: Harvard University Press, 1980; p 65.
8. Gillum RE, Mussolino ME, Madans JH. Coronary heart disease incidence and survival in African-American women and men. The NHANES l epidemiologic follow-up study. Ann Intern Med 1997; 127:111-18.
9. Mogenson EF, Green A. Epidemiology of thyrotoxicosis in Denmark. Incidence and geographical variation in the Funen region 1972-1974. Acta Medica Scand 1980; 208:183-86.
10. Barker DJP, Phillips DHV. Current incidence of thyrotoxicosis and past prevalence of goiter in 12 British towns. Lancet 1984; 2:567-70.
11. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a 20-year follow-up of the Whickham Survey. Clin Endocrinol 1995; 43:55-68.
12. Haraldson A, Gudmundsson ST, Larusson G, et al. Thyrotoxicosis in Iceland 1980-1982. Acta Medica Scand 1985; 217:253-57.
13. Brownlee BEW, Wells JE. The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in North Canterbury, 1983-1985. Clin Endocrin 1990; 33:249-59.
14. Lundgren E, Christensen SB. Decreasing incidence of thyrotoxicosis in an endemic goiter inland area of Sweden. Clin Endocrinol 1990; 33:133-38.
15. Berglund J, Christensen SB, Hallengren B. Total and age-specific incidence of Graves' thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmo. J Intern Med 1990: 227:137-41.
16. Furszyfer J, Kurland LT, McConahey WM, et al. Epidemiological aspects of Hashimoto's thyroiditis and Graves' disease in Rochester, Minnesota (1935-1967) with special reference to temporal trends. Metabolism 1972; 21:197-204.
17. dos Remedios LV, Weber PM, Feldman R, et al. Detecting unsuspected thyroid dysfunction by the free thyroxine index. Arch Intern Med 1980; 140:1045-49.
18. Nagataki S, Shibata V, Inoue S, et al. Thyroid diseases among atomic bomb survivors in Nagasaki. JAMA 1994; 272:364-70.
19. Yamashita S, Sasakawa K. Chernobyl; a decade: Proceedings of the 5th Chernobyl Sasakawa Medical Cooperation Symposium, Kiev, Ukraine October 14-15, 19 97. New York: Elsevier Science, 1997.
20. Nagataki S. Delayed effects of atomic bomb radiation on the thyroid. In: Radiation and the thyroid. Nagataki S (Ed). In: Proceedings of 27th Annual Meeting of the Japanese Nuclear Medicine Society, Nagasaki, Japan; October 1-3, 1987. Amsterdam, Holland: Excerpta Medica, 1989.
21. Rallison ML, Dobyns BM, Meikle AW, et al. Natural history of thyroid abnormalities: prevalence, incidence, and regression of thyroid diseases in adolescents and young adults. Am J Med 1991;91:363-70.
22. National Research Council. Exposure of the American People to Iodine-131 from Nevada Nuclear-Bomb Tests: Review of the National Cancer Institute Report and Public Health Implications Committee on Thyroid Screening Related to 1-131 Exposure. Bethesda, MD: Institute of Medicine, and Committee on Exposure of the American People to 1-131 from the Nevada Atomic Bomb Tests; 1997.
23. de Groot, LJ (Ed). Endocrinology. Philadelphia, PA: W. B. Saunders, 1989.
24. Tunbridge WMG, Evered DC, Hall R, et al. Spectrum of thyroid disease in a community: the Whickham Survey. Clin Endocrinol 1977; 7:481-93.
25. Robbins J, Adams W. Radiation effects in the Marshall Islands. In: Radiation and the thyroid. Nagataki S (Ed). In: Proceedings of 27th Annual Meeting of the Japanese Nuclear Medicine Society, Nagasaki, Japan; October 1-3, 1987. Amsterdam, Holland: Excerpta Medica, 1989, pp. 11-24.
26. Conard RA, Dobyns RM, Sutow WW. Thyroid neoplasia as late effect of exposure to radioactive iodine in fallout. JAMA 1970; 214:316-24.
27. Johnson CJ. Cancer incidence in an area of radioactive fallout downwind from the Nevada test site. JAMA 1984; 251:230-36.
28. Becker DV, Robbins J, Beebe GW, et al. Childhood thyroid cancer following the Chernobyl accident. Endocrinol Metab Clinics 1996; 25:197-211.
29. Nikiforov Y, Gnepp DR, Fagin JA. Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis. J Clin Endocrinol Metab 1996; 81:9-14.
30. Williams D. Thyroid cancer and the Chernobyl accident (Editorial). J Clin Endocrinol Metab 1996; 81:6-8.
31. Robbins J. Lessons from Chernobyl: the event, the aftermath fallout: radioactive, political, social. Thyroid 1997; 7:189-92.
32. Wasnich RD, Grumet FC, Payne RO, et al. Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease. J Clin Endocrinol Metab 1973; 37:703-13.
33. Pilepich MV, Jackson I, Munzenrider JE, et al. Graves' disease following radiation for Hodgkin's disease. JAMA 1978; 24:1381-82.
34. Mahnke DF. Hyperthyroidism associated with radiation for lymphoma. Rocky Mountain Med J 1979; 76:187-88.
35. Fachnie JD, Sudhaker DR. Painless thyroiditis with hyperthyroidism following external radiation to the neck. Henry Ford Hosp Med J 1980; 28:149-51.
36. Blitzer JB, Paolozzi FP, Gottlieb AJ, et al. Thyrotoxic thyroiditis after radiotherapy for Hodgkin's disease. Arch Intern Med 1985; 145:1734-35.
37. Katayama S, Katsutaro S, Piver MS, et al. Radiation associated hyperthyroidism in patients with gynecological malignancies. J Med 1985; 16:587-96.
38. Loeffler JS, Tarbell NJ, Garber JF, et al. Development of Graves' disease following radiation therapy for Hodgkin's disease. Int J Rad Oncol Biol-Phys 1988; 14:175-78.
39. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991; 325:599-605.
40. Nygaard B, Hegedus L, Gervil M, et al. Radioiodine treatment of multinodular nontoxic goitere. Br Med J 1993; 307:828-32.
41. Champlin RE, Kastenberg WE, Gale RP. Radiation accidents and nuclear energy: medical consequences and therapy. Ann Intern Med 1988; 109:730-44.
42. Huysmans DAKC, Hermus ARMM, Edelbroek MAL, et al. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters. Thyroid 1997; 7:535-39.